Combined Chemisorption and Complexation Generate siRNA Nanocarriers with Biophysics Optimized for Efficient Gene Knockdown and Air-Blood Barrier Crossing.


Journal

ACS applied materials & interfaces
ISSN: 1944-8252
Titre abrégé: ACS Appl Mater Interfaces
Pays: United States
ID NLM: 101504991

Informations de publication

Date de publication:
08 Jul 2020
Historique:
pubmed: 10 6 2020
medline: 2 3 2021
entrez: 10 6 2020
Statut: ppublish

Résumé

Current nucleic acid (NA) nanotherapeutic approaches face challenges because of shortcomings such as limited control on loading efficiency, complex formulation procedure involving purification steps, low load of NA cargo per nanoparticle, endosomal trapping, and hampered release inside the cell. When combined, these factors significantly limit the amount of biologically active NA delivered per cell

Identifiants

pubmed: 32515194
doi: 10.1021/acsami.0c06608
pmc: PMC7467563
doi:

Substances chimiques

RNA, Small Interfering 0
Gold 7440-57-5
Polyethyleneimine 9002-98-6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

30095-30111

Références

J Aerosol Med Pulm Drug Deliv. 2013 Feb;26(1):24-30
pubmed: 22856532
Pharm Res. 2008 Dec;25(12):2972-82
pubmed: 18709489
Mol Ther. 2006 Nov;14(5):745-53
pubmed: 16979385
Nat Biotechnol. 2013 Jul;31(7):638-46
pubmed: 23792630
J Control Release. 2019 Sep 28;310:82-93
pubmed: 31398360
Ther Deliv. 2015;6(4):407-9
pubmed: 25996039
Chem Cent J. 2009 Nov 20;3:16
pubmed: 19930546
Methods Mol Biol. 2013;948:171-82
pubmed: 23070770
Mol Ther. 2013 Feb;21(2):300-8
pubmed: 23299796
Part Fibre Toxicol. 2011 May 14;8:16
pubmed: 21569586
Chem Rev. 2015 Oct 14;115(19):11043-78
pubmed: 25872804
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013 Sep-Oct;5(5):484-501
pubmed: 23720168
Proc Natl Acad Sci U S A. 2014 Jul 8;111(27):9739-44
pubmed: 24946803
Mol Ther. 2011 Apr;19(4):676-85
pubmed: 21245850
EMBO Mol Med. 2017 May;9(5):545-557
pubmed: 28289078
Science. 2006 May 19;312(5776):1027-30
pubmed: 16709779
Bioconjug Chem. 2012 Feb 15;23(2):147-57
pubmed: 21992697
Mol Ther. 2011 Dec;19(12):2163-8
pubmed: 21971426
Hum Gene Ther Methods. 2016 Jun;27(3):87-97
pubmed: 27169568
Int J Pharm. 2017 Jun 20;525(2):359-366
pubmed: 28213277
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9138-43
pubmed: 12886020
Methods Mol Biol. 2013;948:105-20
pubmed: 23070766
Anal Chem. 2006 May 15;78(10):3277-81
pubmed: 16689527
ACS Nano. 2013 Nov 26;7(11):9571-84
pubmed: 24144228
Mol Ther. 2013 Jan;21(1):149-57
pubmed: 23032976
Adv Drug Deliv Rev. 2009 Feb 27;61(2):115-27
pubmed: 19146894
Nanomedicine (Lond). 2011 Jun;6(4):715-28
pubmed: 21718180
J Control Release. 2007 Oct 8;122(3):236-45
pubmed: 17692422
Mol Ther Nucleic Acids. 2019 Dec 6;18:774-786
pubmed: 31734558
J Gene Med. 2004 Jul;6(7):769-76
pubmed: 15241784
Adv Funct Mater. 2016 Feb 16;26(7):991-1003
pubmed: 27134622
Eur J Pharm Biopharm. 2013 Jun;84(2):255-64
pubmed: 23079135
Nat Rev Genet. 2014 Aug;15(8):541-55
pubmed: 25022906
Hum Gene Ther. 2017 Dec;28(12):1202-1213
pubmed: 28874076
Hum Gene Ther. 2011 Dec;22(12):1463-73
pubmed: 21644815
J Gene Med. 2004 Oct;6(10):1102-11
pubmed: 15386739
Nano Lett. 2009 May;9(5):2059-64
pubmed: 19331425
PLoS One. 2016 Sep 29;11(9):e0158147
pubmed: 27685846
J Gene Med. 2005 Nov;7(11):1459-67
pubmed: 16041686
ACS Nano. 2013 May 28;7(5):3767-77
pubmed: 23597090
Adv Mater. 2013 Sep 14;25(34):4707-13
pubmed: 23813892
J Mater Chem B. 2018 Nov 21;6(43):6904-6918
pubmed: 32254575
Small. 2014 May 14;10(9):1790-8
pubmed: 24510544
Bioconjug Chem. 2010 Dec 15;21(12):2250-6
pubmed: 21070003
Pharm Res. 2011 Apr;28(4):731-41
pubmed: 20694527
Nanotechnology. 2013 Sep 6;24(35):355101
pubmed: 23940104
Mol Ther. 2015 Apr;23(4):779-89
pubmed: 25586689
Mol Ther Nucleic Acids. 2018 Sep 7;12:207-219
pubmed: 30195760
Nat Mater. 2013 Nov;12(11):967-77
pubmed: 24150415
Hum Vaccin Immunother. 2017 Jun 3;13(6):1-6
pubmed: 28272989
J Am Chem Soc. 2009 Feb 18;131(6):2072-3
pubmed: 19170493
Drug Des Devel Ther. 2009 Feb 06;2:163-88
pubmed: 19920904
Mol Pharm. 2009 Jul-Aug;6(4):1246-60
pubmed: 19606864
Methods Mol Biol. 2019;1943:227-239
pubmed: 30838620
Methods Mol Biol. 2019;1943:347-363
pubmed: 30838628
J Control Release. 2012 Dec 10;164(2):236-46
pubmed: 23064314
ACS Appl Mater Interfaces. 2015 Apr 22;7(15):7891-900
pubmed: 25815610
J Pharm Biomed Anal. 2003 Feb 5;31(1):143-9
pubmed: 12560058

Auteurs

Alexander Taschauer (A)

Faculty of Life Sciences, Center of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, Laboratory of MacroMolecular Cancer Therapeutics (MMCT), University of Vienna, Althanstrasse 14, 1090 Vienna, Austria.

Wolfram Polzer (W)

Faculty of Life Sciences, Center of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, Laboratory of MacroMolecular Cancer Therapeutics (MMCT), University of Vienna, Althanstrasse 14, 1090 Vienna, Austria.

Stefan Pöschl (S)

Faculty of Life Sciences, Center of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, Laboratory of MacroMolecular Cancer Therapeutics (MMCT), University of Vienna, Althanstrasse 14, 1090 Vienna, Austria.

Slavica Metz (S)

Faculty of Life Sciences, Center of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, Laboratory of MacroMolecular Cancer Therapeutics (MMCT), University of Vienna, Althanstrasse 14, 1090 Vienna, Austria.

Nathalie Tepe (N)

Department of Environmental Geosciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria.

Simon Decker (S)

Faculty of Life Sciences, Center of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, Laboratory of MacroMolecular Cancer Therapeutics (MMCT), University of Vienna, Althanstrasse 14, 1090 Vienna, Austria.

Norbert Cyran (N)

Core Facility Cell Imaging and Ultrastructure Research (CIUS), University of Vienna, 1090 Vienna, Austria.

Julia Scholda (J)

Faculty of Life Sciences, Center of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, Laboratory of MacroMolecular Cancer Therapeutics (MMCT), University of Vienna, Althanstrasse 14, 1090 Vienna, Austria.

Julia Maier (J)

Faculty of Life Sciences, Center of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, Laboratory of MacroMolecular Cancer Therapeutics (MMCT), University of Vienna, Althanstrasse 14, 1090 Vienna, Austria.

Hermann Bloß (H)

Faculty of Life Sciences, Center of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, Laboratory of MacroMolecular Cancer Therapeutics (MMCT), University of Vienna, Althanstrasse 14, 1090 Vienna, Austria.

Martina Anton (M)

Institutes of Molecular Immunology and Experimental Oncology, Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany.

Thilo Hofmann (T)

Department of Environmental Geosciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria.

Manfred Ogris (M)

Faculty of Life Sciences, Center of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, Laboratory of MacroMolecular Cancer Therapeutics (MMCT), University of Vienna, Althanstrasse 14, 1090 Vienna, Austria.
Center for NanoScience (CeNS), Ludwig Maximilians University, 80539 Munich, Germany.

Haider Sami (H)

Faculty of Life Sciences, Center of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, Laboratory of MacroMolecular Cancer Therapeutics (MMCT), University of Vienna, Althanstrasse 14, 1090 Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH